Chiglitazar ameliorates dehydroepiandrosterone-induced polycystic ovary syndrome in rats
Abstract Background Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder accompanied by ovulatory dysfunction. Insulin resistance (IR) is a key pathogenic mechanism in PCOS, and insulin sensitizers, such as metformin and pioglitazone, can improve PCOS symptoms. Chiglitazar, a pan-...
Saved in:
Main Authors: | Fuzhen Zhao (Author), Wei Cui (Author), Chengmei Fang (Author), Yuanyuan Luo (Author), Cheng Zhang (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats
by: Gengxiang Wu, et al.
Published: (2020) -
Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes
by: Haowen Wu, et al.
Published: (2023) -
The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome
by: Kok-Min Seow, et al.
Published: (2018) -
Short‐term rapamycin administration elevated testosterone levels and exacerbated reproductive disorder in dehydroepiandrosterone‐induced polycystic ovary syndrome mice
by: Zaixin Guo, et al.
Published: (2021) -
The effect of hydroalcoholic extract of Nigella Sativa seed on dehydroepiandrosterone-induced polycystic ovarian syndrome in rats: An experimental study
by: Samira Khani, et al.
Published: (2021)